Molecular profiling of papillary thyroid carcinomas in healthcare workers exposed to low dose radiation at the workplace

Endocrine. 2022 Apr;76(1):95-100. doi: 10.1007/s12020-021-02972-y. Epub 2022 Jan 30.

Abstract

Purpose: Exposure to ionizing radiation, especially during childhood, is a well-established risk factor for thyroid cancer. The vast majority of radiation-induced cancers are papillary carcinomas (PTCs). These tumors typically have gene fusions in contrast to point mutations prevalent in sporadic PTCs. The aim of this study was to investigate the molecular profiles of PTC patients with workplace exposure to ionizing radiation.

Methods: A retrospective review of 543 patients who underwent surgery with diagnosis of PTC was performed. A cohort of nine healthcare specialists previously exposed to radiation sources during their professional practice was selected and analyzed using the ThyroSeq mutation panel for point mutations and gene fusions associated with thyroid cancer.

Results: The molecular analysis of surgical samples of PTCs was informative and revealed genetic alterations in five patients. BRAF V600E was found in four (67%) cases whereas RET/PTC1 fusion in one (17%) and one sample (17%) was wild type for point mutations and fusions. One sample completely failed molecular analysis while two others were negative for genes fusions but failed DNA analysis; these three samples were excluded.

Conclusions: In this limited cohort of healthcare workers exposed to low dose of ionizing radiation at the workplace and developed PTC, the molecular profiling determined BRAF V600E point mutation as the most common event, arguing against the role of workplace radiation exposure in the etiology of these tumors.

Keywords: Healthcare specialists; Papillary thyroid carcinoma (PTC); Radiation; ThyroSeq; Thyroid cancer.

MeSH terms

  • Carcinoma, Papillary* / pathology
  • Health Personnel
  • Humans
  • Mutation
  • Proto-Oncogene Proteins B-raf / genetics
  • Thyroid Cancer, Papillary / genetics
  • Thyroid Cancer, Papillary / pathology
  • Thyroid Neoplasms* / etiology
  • Thyroid Neoplasms* / genetics
  • Workplace

Substances

  • Proto-Oncogene Proteins B-raf